Timothy J. Sangiovanni, VP, Corporate Controller at KEMPHARM, INC (KMPH), bought 4,000 shares at $0.20 ($800) on 2020-03-13, disclosed to the SEC on 2020-03-16.
Open-market purchase of $800 KMPH by VP, Corporate Controller. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| ZVRA | SELL | 2025-02-14 | $24K | — | Filing → |
| ZVRA | BUY | 2023-03-13 | $5K | — | Filing → |
| KMPH | BUY | 2020-03-10 | $2K | — | Filing → |